Outcome Measures for Clinical Trials in Down Syndrome.

The paper reports no patient outcomes and no treatment effects. The measure classifications rest on expert opinion, literature review, and input from a sponsored meeting. The tables are not available, so the full measure list cannot be checked. Many measures were judged from studies in other intellectual disabilities, not specifically in Down syndrome. Adaptive behavior scores may not compare fairly across countries because norms are mainly US-based. The paper is about clinical-trial outcome measures, so it does not tell a therapist which measure is best for individual care.

The supplied text reports an NIH-sponsored meeting and input from NIH, FDA, pharmaceutical companies, advocacy organizations, and a medical outcomes working group. It does not give an author conflict-of-interest declaration.

Do not treat these measures as validated clinical tools for Down syndrome. The paper says no language measure is completely validated, and many promising measures still need Down syndrome-specific evaluation.